Progress towards gene therapy for cystic fibrosis

Expert Opinion on Drug Delivery

Volumn 2, Issue 2, 2005, Pages 269-280

  Tate, Stephen ^a   Elborn, Stuart ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Adeno associated virus; Adenoviral; Animal model; Cystic fibrosis; Gene therapy; Liposome

Indexed keywords

CHIMERIC PROTEIN; COMPLEMENTARY DNA; EGTAZIC ACID; LENTIVIRUS VECTOR; LIPOSOME; LIPOSOME GL 67; MACROGOL; MESSENGER RNA; NAKED DNA; PARVOVIRUS VECTOR; PLASMID DNA; POLYCATION; POLYLYSINE; SODIUM DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; CLINICAL TRIAL; CPG ISLAND; CYSTIC FIBROSIS; DISEASE MODEL; DRUG EFFICACY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HUMAN; MOLECULAR CLONING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; SENDAI VIRUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CATIONS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; ELECTROPORATION; EPITHELIAL CELLS; FORECASTING; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; LIPOSOMES; LUNG; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PLASMIDS; SENDAI VIRUS;

EID: 23644446289     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.2.269     Document Type: Review

References (87)

1. WELSH MJ, SMITH AE: Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell (1993) 73:1251-1254.
2. + absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. (2004) 10(5):487-493.
3. FRIZZELL RA, PILEWSKI JM: Finally, mice with CF lung disease. Nat. Med. (2004) 10(5):452-454.
4. ROMMENS JM, IANUZZI MC, KEREM B-S et al.: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 245:1059-1065.
5. KEREM BS, ROMMENS JM, BUCHANAN et al.: Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 245:1073-1080.
6. RIORDAN JR, ROMMENS JM, KEREM B-S et al.: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 245:1066-1073.
7. ALTON EW, MIDDLETON PG, CAPLEN NJ et al.: Noninvasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. (1993) 5:135-142.
8. HYDE SC, GILL DR, HIGGINS CF et al.: Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature (1993) 362:250-255.
9. FERRARI S, GEDDES DM, ALTON E: Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv. Drug Deliv. Rev. (2002) 54(11):1373-1393.
10. ZHOU R, GEIGER RC, DEAN DA: Intracellular trafficking of nucleic acids. Expert Opin. Drug Deliv. (2004) 1(1):127-140.
11. LEE ER, MARSHALL J, SIEGEL CS et al.: Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. (1996) 7:1701-1717.
12. FELGNER PL: Improvements in cationic liposomes for in vivo gene transfer. Hum. Gene Ther. (1996) 7:1791-1793.
13. CAPLEN NJ, ALTON EW, MIDDLETON PG et al.: Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. (1995) 1:39-46.
14. GILL DR, SOUTHERN KW, MOFFORD KA, SEDDON T et al.: A placebo controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (1997) 4:199-209.
15. PORTEOUS DJ, DORIN JR, MCLACHLAN G et al.: Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (1997) 4:210-218.
16. HYDE SC, SOUTHERN KW, GILEADI U et al.: Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (2000) 7:1156-1165.
17. CHADWICK SL, KINGSTON HD, STERN M et al.: Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers. Gene Ther. (1997) 4:937-942.
18. ALTON EW, STERN M, FARLEY R et al.: Cationic lipid mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 353:947-954.
19. RUIZ FE, CLANCY JP, PERRICONE MA et al.: 2001. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum. Gene Ther. (2001) 12:751-761.
20. KRIEG AM: Direct immunologic activities of CpG DNA and implications for gene therapy. J. Gene Med. (1999) 1:56-63.
21. MATSUI H, JOHNSON LG, RANDELL SH, BOUCHER RC: Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J. Biol. Chem. (1997) 272:1117-1126.
22. ZIADY AG, DAVIS PB, KONSTAN MW: Non-viral gene transfer for cystic fibrosis. Expert. Opin. Biol. Ther. (2003) 3:449-458.
23. MONTIER T, DELEPINE P, PICHON C, FEREC C, PORTEOUS DJ, MIDOUX P: Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol. (2004) 22(11):586-592.
24. FAJAC I, THEVENOT G, BEDOUET L et al.: Uptake of plasmid/glycosylated polymer complexes and gene transfer efficiency in differentiated airway epithelial cells. J. Gene Med. (2003) 5(1):38-48.
25. ZIADY AG, KELLEY T, MILLIKEN E, FERKOL T, DAVIS PB: Functional evidence of CFTR gene transfer in nasal epithelium of CF mice following luminal application of DNA complexes targeted to the SEC receptor. Mol. Ther. (2002) 5:413-419.
26. JIANG C, O'CONNOR SP, FANG SL et al.: Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum. Gene Ther. (1998) 9:1531-1542.
27. POLLARD H, REMY JS, LOUSSOUARN G et al.: Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem (1998) 273:7507-7511.
28. LIU G, LI D, PASUMARTHY MK et al.: Nanoparticles of compacted DNA transfect post mitotic cells. J. Biol. Chem. (2003) 278:32578-32586.
29. ZIADY AG, GEDEON CR, MILLER T et al.: Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo. Mol. Ther. (2003) 8(6):936-947.
30. KONSTAN M, WAGENER JS, HILLIARD KA et al.: Single dose escalation study to evaluate safety of nasal administration of CFTR001 gene transfer vector to subjects with cystic fibrosis. Mol. Ther. (2003) 7:S386.
31. ESCRIOU V, CARRIÈRE M, SCHERMAN D, WILS P: NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv. Drug Deliv. Rev. (2003) 55:295-306.
32. YEW NS, ZHAO H, WU IH et al.: Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. (2000) 1:255-262.
33. GILL DR, SMYTH SE, GODDARD CA et al.: Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter. Gene Ther. (2001) 8(20):1539-46.
34. KOEHLER DR, HANNAM V, BELCASTRO R et al.: Targeting transgene expression for cystic fibrosis gene therapy. Mol. Ther. (2001) 4(1)58-65.
35. DEAN DA: Electroporation of the vasculature and the lung. DNA Cell Biol. (2003) 22(12):797-806.
36. GRAHAM FL, PREVEC L: Methods for construction of adenovirus vectors. Mol. Biotechnol. (1995) 3:207-220.
37. KOVESDI I, BROUGH DE, BRUDER JT, WICKHAM TJ: Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol (1997) 8:583-589.
38. BENIHOUD K, YEH P, PERRICAUDET M: Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. (1999) 10(5):440-447.
39. ROSENFELD MA, YOSHIMURA K, TRAPNELL BC et al.: In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell (1992) 68:143-155.
40. YANG Y, NUNES FA, BERENCSI K et al.: Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. (1994) 7:362-369.
41. GRUBB BR, PICKLES RJ, YE H et al.: Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (1994) 371:802-806.
42. ENGELHARDT JF, YANG Y, STRATFORD-PERRICAUDET LD et al.: Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat. Genet. (1993) 4:27-34.
43. ZABNER J, COUTURE LA, GREGORY RJ et al.: Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell (1993) 75:207-216.
44. HAY JG, MCELVANEY NG, HERENA J, CRYSTAL RG: Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum. Gene Ther. (1995) 6:1487-1496
45. KNOWLES MR, HOHNEKER KW, ZHOU Z et al.: A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. (1995) 333:823-823.
46. WALTERS RW, GRUNST T, BERGELSON JM et al.: Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem. (1999) 274:10219-10226.
47. GREGORY LG, HARBOTTLE RP, LAWRENCE L et al.: Enhancement of adenovirus mediated transfer to the airways by DEAE dextran and sodium caprate in vivo. Mol. Ther. (2003) 7(1):19-26.
48. VAN HEECKEREN AM, SCARIA A, SCHLUCHTER MD, FERKOL TW, WADSWORTH S, DAVIS PB: Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. Am. J. Physiol. Lung Cell. Mol. Physiol. (2004) 286:L717-L726.
49. JOHNSON LG, VANHOOK MK, COYNE CB et al.: Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum. Gene Ther. (2003) 14(8):729-747.
50. YANG Y, LI Q, ERTL HC, WILSON JM: Cellular and humoral immune responses to viral antigens create barriers to lung directed gene therapy with recombinant adenoviruses. J. Virol. (1995) 69:2004-2015.
51. TOSI MF, VAN HEECKEREN A, FERKOL TW et al.: Effect of Pseudomonas-induced chronic lung inflammation on specific cytotoxic T-cell responses to adenoviral vectors in mice. Gene Ther. (2004) 11(19):1427-1433.
52. KIM IH, JOZKOWICZ A, PIEDRA P et al.: Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. USA (2001) 98:13282-13287.
53. SCHIEDNER G, MORRAL N, PARKS RJ et al.: Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. (1998) 18:180-183.
54. MORRAL N, PARKS RJ, ZHOU H et al.: High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity. Hum. Gene Ther. (1998) 9:2709-2716.
55. MORRAL N, O'NEAL W, RICE K et al.: Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA (1999) 96:12816-12821.
56. TOIETTA G, KOEHLER DR, FINEGOLD M et al.: Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a k18 promoter. Mol. Ther. (2003) 7:649-658.
57. FLOTTE TR, AFIONE SA, CONRAD CK et al.: Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA (1993) 90:10613-10617.
58. AFIONE SA, CONRAD CK, KEARNS WG et al.: In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. (1996) 70:3235-3241.
59. CONRAD CK, ALLEN SS, AFIONE SA et al.: Safety of single-dose administration of an adeno-associated virus (AAV)- CFTR vector in the primate lung. Gene Ther. (1996) 3:658-668.
60. FLOTTE T, CARTER B, CONRAD CK et al.: A Phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. (1996) 7:1145-1159.
61. WAGNER JA, MORAN ML, MESSNER AH et al.: A Phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. Hum. Gene Ther. (1998) 9:889-909.
62. WAGNER JA, NEPOMUCENO IB, MESSNER AH et al.: A Phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. (2002) 13:1349-1359.
63. AITKEN ML, MOSS RB, WALTZ DA et al.: A Phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. (2001) 12:1907-1916.
64. AURICCHIO A, O'CONNOR E, WEINER D et al.: Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J. Clin. Invest. (2002) 110(4):499-504.
65. SIRNINGER J, MULLER C, BRAAG S et al.: Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector. Hum. Gene Ther. (2004) 15(9):832-841.
66. MOSS RB, RODMAN D, SPENCER LT et al.: Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest (2004) 125(2):509-521.
67. YONEMITSU Y, KITSON C, FERRARI S et al.: Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat. Biotechnol. (2000) 18(9):970-973.
68. GRIESENBACH U, CASSADY RL, FERRARI S et al.: The nasal epithelium as a factory for systemic protein delivery. Mol. Ther. (2002) 5(2):98-103.
69. FERRARI S, GRIESENBACH U, SHIRAKI-IIDA T et al.: A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther. (2004) 11(22):1659-1664.
70. INOUE M, TOKUSUMI Y, BAN H, KANAYA T, TOKUSUMI T, NAGAI Y et al.: Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J. Virol. (2003) 77(5):3238-3246.
71. KOBAYASHI M, IIDA A, UEDA Y, HASEGAWA M: Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol. (2003) 77(4):2607-2614.
72. SINN PL, HICKEY MA, STABER PD et al. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. (2003) 77(10):5902-5910.
73. DE SEMIR D, PETRIZ J, AVINYO A et al.: Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells. J. Gene Med. (2002) 4:308-322.
74. GONCZ KK, COLOSIMO A, DALLAPICCOLA B, GAGNE L, HONG K: Expression of ΔF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Ther. (2001) 8:961-965.
75. LIU X, JIANG Q, MANSFIELD SG et al.: Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. (2002) 20(1):47-52.
76. MANSFIELD SG, CHAO H, WALSH CE: RNA repair using spliceosome-mediated RNA trans-splicing. Trends Mol. Med. (2004) 10(6):263-268.
77. CORMET-BOYAKA E, JABLONSKY M, NAREN AP, JACKSON PL, MUCCIO DD, KIRK KL: Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Proc. Natl. Acad. Sci. USA (2004) 101(21):8221-8226.
78. DAVIDSON DJ, ROLFE M: Mouse models of cystic fibrosis. Trends Genet. (2001) 17:S29-S37.
79. DAVIDSON DJ, DORIN JR, MCLACHLAN G et al.: Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat. Genet. (1995) 9:351-357.
80. VAN HEECKEREN A, WALENGA R, KONSTAN MW et al.: Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with pseudomonas aeruginosa. J. Clin. Inv. (1997) 100:2810-2815.
81. VAN HEECKEREN A, FERKOL T, TOSI M: Effects of bronchopulmonary inflammation induced by Pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Ther. (1998) 5:345-351.
82. -/-) mice. Infect. Immun. (2001) 69:5138-5150.
83. KOEHLER DR, SAJJAN U, CHOW YH et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc. Natl Acad. Sci. USA (2003) 100:15364-15369.
84. PACK RJ, AL-UGAILY LH, MORRIS G: The cells of the tracheobronchial epithelium of the mouse: a quantitative light and electron microscope study. J. Anat (1981) 132:71-84.
85. ROCHELLE LG, LI DC, YE H et al.: Distribution of ion transport mRNAs throughout murine nose and lung. Am. J. Physiol. Lung Cell. Mol. Physiol. (2000) 279:L14-L24.
86. EMERSON E, RENWICK L, TATE S et al.: Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments. Mol. Ther. (2003) 8(4):646-653.
87. LI Z, ENGELHARDT JF: Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer. Reprod. Biol. Endocrinol. (2003) 1(1):83.